BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 33774157)

  • 41. CRISPR-CBEI: a Designing and Analyzing Tool Kit for Cytosine Base Editor-Mediated Gene Inactivation.
    Yu H; Wu Z; Chen X; Ji Q; Tao S
    mSystems; 2020 Sep; 5(5):. PubMed ID: 32963098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Base Editing Landscape Extends to Perform Transversion Mutation.
    Molla KA; Qi Y; Karmakar S; Baig MJ
    Trends Genet; 2020 Dec; 36(12):899-901. PubMed ID: 32951947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The "new favorite" of gene editing technology-single base editors.
    Wei Y; Zhang XH; Li DL
    Yi Chuan; 2017 Dec; 39(12):1115-1121. PubMed ID: 29258982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Designing an Elusive C•G→G•C CRISPR Base Editor.
    Gajula KS
    Trends Biochem Sci; 2019 Feb; 44(2):91-94. PubMed ID: 30446374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Web-Based Base Editing Toolkits: BE-Designer and BE-Analyzer.
    Hwang GH; Bae S
    Methods Mol Biol; 2021; 2189():81-88. PubMed ID: 33180295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CRISPR/Cas-Mediated Base Editing: Technical Considerations and Practical Applications.
    Molla KA; Yang Y
    Trends Biotechnol; 2019 Oct; 37(10):1121-1142. PubMed ID: 30995964
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Design and Application of DNA-Editing Enzymes as Base Editors.
    Rallapalli KL; Komor AC
    Annu Rev Biochem; 2023 Jun; 92():43-79. PubMed ID: 37018843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.
    Liu Z; Shan H; Chen S; Chen M; Song Y; Lai L; Li Z
    FASEB J; 2020 Jan; 34(1):588-596. PubMed ID: 31914687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Web-based design and analysis tools for CRISPR base editing.
    Hwang GH; Park J; Lim K; Kim S; Yu J; Yu E; Kim ST; Eils R; Kim JS; Bae S
    BMC Bioinformatics; 2018 Dec; 19(1):542. PubMed ID: 30587106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Base Editing in Poplar Through an Agrobacterium-Mediated Transformation Method.
    Li G; Sretenovic S; Coleman G; Qi Y
    Methods Mol Biol; 2023; 2653():53-71. PubMed ID: 36995619
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Powerful Microbial Base-Editing Toolbox: From Optimization Strategies to Versatile Applications.
    Li K; Qin LY; Zhang ZX; Yan CX; Gu Y; Sun XM; Huang H
    ACS Synth Biol; 2023 Jun; 12(6):1586-1598. PubMed ID: 37224027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors.
    Wang D; Zhang F; Gao G
    Cell; 2020 Apr; 181(1):136-150. PubMed ID: 32243786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis.
    Zhou C; Sun Y; Yan R; Liu Y; Zuo E; Gu C; Han L; Wei Y; Hu X; Zeng R; Li Y; Zhou H; Guo F; Yang H
    Nature; 2019 Jul; 571(7764):275-278. PubMed ID: 31181567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos.
    Chen L; Hong M; Luan C; Gao H; Ru G; Guo X; Zhang D; Zhang S; Li C; Wu J; Randolph PB; Sousa AA; Qu C; Zhu Y; Guan Y; Wang L; Liu M; Feng B; Song G; Liu DR; Li D
    Nat Biotechnol; 2024 Apr; 42(4):638-650. PubMed ID: 37322276
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
    Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
    Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delivering Base Editors In Vivo by Adeno-Associated Virus Vectors.
    Lim CKW; Miskalis AJ; Perez-Pinera P; Gaj T
    Methods Mol Biol; 2023; 2606():135-158. PubMed ID: 36592313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytosine base editors (CBEs) for inducing targeted DNA base editing in Nicotiana benthamiana.
    Luo J; Abid M; Tu J; Cai X; Zhang Y; Gao P; Huang H
    BMC Plant Biol; 2023 Jun; 23(1):305. PubMed ID: 37286962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imperfect guide-RNA (igRNA) enables CRISPR single-base editing with ABE and CBE.
    Zhao D; Jiang G; Li J; Chen X; Li S; Wang J; Zhou Z; Pu S; Dai Z; Ma Y; Bi C; Zhang X
    Nucleic Acids Res; 2022 Apr; 50(7):4161-4170. PubMed ID: 35349689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.